Estimation of Oral Bioavailability of a Long Half-Life Drug in Healthy Subjects
暂无分享,去创建一个
[1] R. Gregg,et al. Orally active squalene synthase inhibitors: bis((acyloxy)alkyl) prodrugs of the alpha-phosphonosulfonic acid moiety. , 1996, Journal of medicinal chemistry.
[2] E. Stein. Drug and alternative therapies for hyperlipidemia. , 1994, Atherosclerosis.
[3] B. Arison,et al. Isopentenoid synthesis in isolated embryonic Drosophila cells. Farnesol catabolism and omega-oxidation. , 1988, The Journal of biological chemistry.
[4] J. D. Karkas,et al. Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.